NICE IMMUNO-ONCOLOGY APPRAISALS: COMPARISON OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL ANALYSIS METHODS AND CRITIQUE

被引:0
|
作者
Chalmers, K. [1 ]
Pagotto, A. [1 ]
Langford, B. [1 ]
Diamantopoulos, A. [1 ]
Rinciog, C. [1 ]
机构
[1] Symmetron Ltd, London, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HTA245
引用
收藏
页码:S344 / S344
页数:1
相关论文
共 50 条
  • [1] Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials
    Wang, Zi-Xian
    Wu, Hao-Xiang
    Xie, Li
    Lin, Wu-Hao
    Liang, Fei
    Li, Jin
    Yang, Zhi-Min
    Xu, Rui-Hua
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (04)
  • [2] INDIRECT TREATMENT COMPARISON METHODS IN NICE IMMUNO-ONCOLOGY TECHNOLOGY APPRAISALS: IMPLEMENTATION AND CRITIQUE
    Pagotto, A.
    Langford, B.
    Rinciog, C.
    Sawyer, L.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S341 - S342
  • [3] CRITIQUES OF SURVIVAL ANALYSIS METHODS USED IN IMMUNO-ONCOLOGY APPRAISALS ASSESSED BY NICE IN THE UK, 2011-2020
    Kontogiannis, V
    Pagotto, A.
    Chalmers, K.
    Goncalves-Bradley, D.
    Langford, B.
    Rinciog, C.
    Sawyer, L.
    Diamantopoulos, A.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S189 - S189
  • [4] OVERALL SURVIVAL VERSUS PROGRESSION-FREE SURVIVAL IN ONCOLOGY CLINICAL TRIALS
    Aissaoui, A.
    Bin Sawad, A.
    Turkistani, F.
    Aissaoui, N.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A717 - A717
  • [5] Progression-free survival, overall survival and quality of life: What is their medicoeconomic importance in oncology?
    Pavlovic, Mira
    Garnier, Jerome
    Durand-Zaleski, Isabelle
    Bilbault, Pascal
    Gaudin, Anne-Francoise
    Le Jeunne, Claire
    Lalaude, Olivier
    Roze, Stephane
    De Sahb, Rima
    Sapede, Claudine
    [J]. THERAPIE, 2016, 71 (01): : 59 - 67
  • [6] Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
    Belin, Lisa
    Tan, Aidan
    De Rycke, Yann
    Dechartres, Agnes
    [J]. BRITISH JOURNAL OF CANCER, 2020, 122 (11) : 1707 - 1714
  • [7] THE ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ONCOLOGY TRIALS: A SIMULATION EXERCISE
    Wu, D. B. C.
    Manjula, I. S.
    Yu, D.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S198 - S198
  • [8] Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
    Lisa Belin
    Aidan Tan
    Yann De Rycke
    Agnès Dechartres
    [J]. British Journal of Cancer, 2020, 122 : 1707 - 1714
  • [9] IMPROVED ESTIMATION OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL FOR STATE TRANSITION MODELLING IN ONCOLOGY
    Wigfield, P.
    Heeg, B.
    Ouwens, M.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S6 - S6
  • [10] Progression-free survival, overall survival and quality of life: What is their medicoeconomic importance in oncology?
    Pavlovic, Mira
    Garnier, Jerome
    Durand-Zaleski, Isabelle
    Bilbault, Pascal
    Gaudin, Anne-Francoise
    Le Jeunne, Claire
    Lalaude, Olivier
    Roze, Stephane
    de Sahb, Rima
    Sapede, Claudine
    [J]. THERAPIE, 2016, 71 (06): : 625 - 632